Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMDP) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to -$0.1.

  • LifeMD's EPS (Basic) rose 2307.69% to -$0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.22, marking a year-over-year increase of 6507.94%. This contributed to the annual value of -$0.6 for FY2024, which is 1487.55% up from last year.
  • Per LifeMD's latest filing, its EPS (Basic) stood at -$0.1 for Q3 2025, which was up 2307.69% from -$0.05 recorded in Q2 2025.
  • LifeMD's 5-year EPS (Basic) high stood at -$0.02 for Q1 2025, and its period low was -$0.7 during Q4 2021.
  • For the 5-year period, LifeMD's EPS (Basic) averaged around -$0.29, with its median value being -$0.2 (2023).
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 13703.7% in 2021, then skyrocketed by 8828.25% in 2025.
  • Quarter analysis of 5 years shows LifeMD's EPS (Basic) stood at -$0.7 in 2021, then surged by 41.61% to -$0.41 in 2022, then skyrocketed by 67.6% to -$0.13 in 2023, then fell by 4.33% to -$0.14 in 2024, then increased by 27.92% to -$0.1 in 2025.
  • Its EPS (Basic) was -$0.1 in Q3 2025, compared to -$0.05 in Q2 2025 and -$0.02 in Q1 2025.